| Literature DB >> 25554072 |
Marja Bosaeus1, Aysha Hussain, Therese Karlsson, Louise Andersson, Lena Hulthén, Cecilia Svelander, Ann-Sofie Sandberg, Ingrid Larsson, Lars Ellegård, Agneta Holmäng.
Abstract
BACKGROUND: Fish and meat intake may affect gestational weight gain, body composition and serum fatty acids. We aimed to determine whether a longitudinal dietary intervention during pregnancy could increase fish intake, affect serum phospholipid fatty acids, gestational weight gain and body composition changes during pregnancy in women of normal weight participating in the Pregnancy Obesity Nutrition and Child Health study. A second aim was to study possible effects in early pregnancy of fish intake and meat intake, respectively, on serum phospholipid fatty acids, gestational weight gain, and body composition changes during pregnancy.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25554072 PMCID: PMC4292819 DOI: 10.1186/1475-2891-14-1
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 3.271
Figure 1Pregnancy obesity nutrition and child health study protocol. Recruitment process, randomization and study visit flow in the control and intervention groups. Trimester 1, pregnancy weeks 8–12; trimester 2, pregnancy weeks 24–26; trimester 3, pregnancy weeks 35–37.
Figure 2Recruitment, randomization, participation, drop-outs, exclusion and final data analysis groups of normal weight women in the pregnancy obesity nutrition and child health study. Flow chart illustrating the number of normal weight women that were recruited, were randomized to intervention or control groups, participated in study visits, and were drop-outs. Women were excluded for miscarriage after trimester 1 (n = 2), intrauterine fetal death (n = 1), duplex pregnancy (n = 1), sudden infant death syndrome (n = 1), abortion (n = 1), and delivery before pregnancy week 34 (n = 1). For data analyses, we defined two populations: a) a pooled “early pregnancy” population at baseline and b) a subpopulation of all women who participated in all 3 trimesters.
Early pregnancy: characteristics at baseline
| Control group 2 | Intervention group 3 | P 7 | |
|---|---|---|---|
| Age (years) | 31.2 (4.0) | 31.4 (3.9) | 0.84 |
| Weight (kg) | 63.8 (6.4) | 61.5 (5.8) | 0.12 |
| Height (cm) | 170 (6.7) | 167 (6.3) | 0.08 |
| Body mass index (kg/m2) | 22.0 (1.3) | 22.0 (1.6) | 0.88 |
| Waist circumference (cm) | 79.4 (4.8) | 80.4 (6.6) | 0.48 |
| Fat mass (kg) | 16.8 (3.5) | 16.3 (4.3) | 0.60 |
| Fat-free mass (kg) | 47.0 (4.8) | 45.2 (4.6) | 0.11 |
| Parity (n)4 | 0 (0, 1) | 0 (0, 1) | 0.466 |
| 15 or more years of education5 | 26 (72.2) | 28 (75.7) | |
| Plasma glucose (mmol/L) | 4.4 (0.4) | 4.4 (0.4) | 0.90 |
| Serum insulin (mU/L) | 5.0 (2.5) | 5.1 (3.4) | 0.88 |
| QUICKI8 | 0.340 (0.050) | 0.337 (0.044) | 0.81 |
1Mean (SD) unless noted otherwise. 2n = 35-36. 3n = 34-37. 4Median with interquartile range (25th percentile, 75th percentile). 5n (%). 6Analyzed by Mann–Whitney U test. 7P values were calculated with Student’s independent-sample t test. 8Quantitative insulin sensitivity check index.
Subgroups: characteristics at baseline of women who participated in all three trimesters
| Control group 2 | Intervention group 3 | P 5 | |
|---|---|---|---|
| Age (years) | 30.6 (29.0, 32.5) | 32.2 (30.3, 33.3) | 0.19 |
| Weight (kg) | 63.7 (60.1, 68.0) | 61.9 (59.0, 65.1) | 0.32 |
| Height (cm) | 173 (167, 178) | 166 (162, 173) | 0.05 |
| Body mass index (kg/m2) | 22.3 (20.9, 22.7) | 22.3 (20.9, 23.3) | 0.62 |
| Waist circumference (cm) | 80.0 (77.5, 82.5) | 81.9 (78.0, 86.0) | 0.26 |
| Fat mass (kg) | 16.0 (14.5, 18.9) | 16.6 (12.1, 22.1) | 0.90 |
| Fat-free mass (kg) | 47.3 (44.7, 52.9) | 45.6 (41.5, 49.1) | 0.15 |
| Parity (n) | 0 (0, 1) | 0.5 (0, 1) | 0.26 |
| 15 or more years of education4 | 15 (88.2) | 17 (94.4) | |
| Plasma glucose (mmol/L) | 4.3 (4.3, 4.8) | 4.3 (4.3, 4.5) | 0.83 |
| Serum insulin (mU/L) | 4.9 (4.3, 5.6) | 4.6 (4.0, 5.6) | 0.70 |
| QUICKI6 | 0.323 (0.307, 0.340) | 0.338 (0.312, 0.352) | 0.47 |
1Median with interquartile range (25th percentile, 75th percentile) unless noted otherwise. 2n = 17. 3n = 17-18. 4n (%). 5P values were calculated by Mann–Whitney U test. 6Quantitative insulin sensitivity check index.
Reported intake of fish, meat, and energy in all three trimesters
| Fish intake (g/week) | Meat intake (g/week) | Energy intake (kcal/day) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Trimester | Control group2 | Intervention group3 | P5 | Control group2 | Intervention group3 | P5 | Control group2 | Intervention group3 | P5 |
| 1st | 450 (300, 600) | 300 (150, 450) | 0.10 | 1050 (788, 1750) | 963 (525, 1269) | 0.26 | 2282 (1992, 2936) | 2161 (1814, 2335) | 0.25 |
| 2nd | 450 (300, 600) | 413 (225, 488)6 | 0.78 | 1225 (700, 1750) | 1006 (678, 1312) | 0.29 | 2419 (2026, 2878) | 2196 (2008, 2510) | 0.44 |
| 3rd | 450 (300, 525) | 375 (300, 600)7 | 0.88 | 1400 (700, 1925) | 1007 (875, 1269) | 0.21 | 2330 (2010, 2678) | 2364 (2033, 2860) | 0.72 |
| P4 | 0.98 | 0.006 | 0.49 | 0.35 | 0.44 | 0.66 | |||
1Values are medians with interquartile range (25th percentile, 75th percentile). 2n = 15-17. 3n = 18. 4Friedman test analyses within treatment groups, followed by post-hoc Wilcoxon signed-rank tests. 5Differences between groups in each trimester were analyzed by Mann–Whitney U tests. 6P = 0.03 between the first and second trimesters. 7P = 0.01 between the first and third trimesters.
Serum concentrations of ARA (arachidonic acid) (mg/mL), EPA (eicosapentaenoic acid) (mg/mL), and DHA (docosahexaenoic acid) (mg/mL) in all three trimesters
| ARA (mg/mL) | EPA (mg/mL) | DHA (mg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Trimester | Control group2 | Intervention group3 | P5 | Control group2 | Intervention group3 | P5 | Control group2 | Intervention group3 | P5 |
| 1st | 0.185 | 0.193 | 0.027 | 0.030 | 0.132 | 0.154 | |||
| (0.153, 0.222) | (0.167, 0.232) | 0.46 | (0.017, 0.040) | (0.018, 0.043) | 0.76 | (0.110, 0.157) | (0.115, 0.174) | 0.37 | |
| 2nd | 0.202 | 0.216 | 0.027 | 0.035 | 0.162 | 0.189 | |||
| (0.187, 0.240)6 | (0.174, 0.235)9 | 0.83 | (0.019, 0.051) | (0.020, 0.045) | 0.66 | (0.137, 0.203)12 | (0.159, 0.261)13 | 0.12 | |
| 3rd | 0.227 | 0.231 | 0.024 | 0.042 | 0.196 | 0.197 | |||
| (0.189, 0.256)7 | (0.195, 0.270)8,10 | 0.64 | (0.018, 0.040) | (0.019, 0.066) | 0.16 | (0.155, 0.217)11 | (0.145, 0.267)14 | 0.48 | |
| P4 | 0.01 | <0.001 | 0.63 | 0.12 | <0.001 | <0.001 | |||
1Values are medians with interquartile range (25th percentile, 75th percentile). 2n = 17 (for all time points). 3n = 18 (for all time points). 4Friedman test within each treatment group, followed by post-hoc Wilcoxon signed-rank tests. 5Differences between groups in each trimester were analyzed by Mann–Whitney U tests.6P = 0.01 between first and second trimesters. 7P = 0.006 between first and third trimesters. 8P = 0.004 between first and third trimesters. 9P = 0.006 between first and second trimesters. 10P = 0.02 between second and third trimesters. 11P < 0.001 between first and third trimesters. 12P = 0.002 between first and second trimesters. 13P = 0.003 between first and second trimesters. 14P = 0.003 between second and third trimesters.
Spearman’s rank correlations between fish intake (grams/week), meat intake (grams/week), and serum concentrations of ARA (arachidonic acid) (mg/mL), EPA (eicosapentaenoic acid) (mg/mL), and DHA (docosahexaenoic acid) (mg/mL) in all three trimesters
| Control group 1,3 | Intervention group 2 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARA mg/mL | P | EPA mg/mL | P | DHA mg/mL | P | ARA mg/mL | P | EPA mg/mL | P | DHA mg/mL | P | |
| Fish intake grams/week | ||||||||||||
| 1st trimester | 0.09 | 0.73 | 0.50* | 0.04 | 0.46 | 0.07 | 0.16 | 0.53 | 0.78* | <0.001 | 0.69* | 0.002 |
| 2nd trimester | 0.42 | 0.10 | 0.33 | 0.20 | 0.56* | 0.02 | -0.12 | 0.64 | 0.07 | 0.79 | 0.06 | 0.82 |
| 3rd trimester | 0.02 | 0.94 | 0.00 | 0.99 | 0.15 | 0.58 | 0.08 | 0.75 | 0.45 | 0.06 | 0.22 | 0.39 |
| Meat intake grams/week | ||||||||||||
| 1st trimester | 0.26 | 0.31 | -0.06 | 0.82 | 0.11 | 0.66 | 0.37 | 0.13 | -0.08 | 0.76 | 0.37 | 0.14 |
| 2nd trimester | 0.02 | 0.95 | -0.59* | 0.02 | -0.28 | 0.31 | 0.19 | 0.46 | 0.06 | 0.82 | 0.21 | 0.40 |
| 3rd trimester | 0.04 | 0.88 | -0.04 | 0.89 | -0.02 | 0.95 | -0.03 | 0.91 | 0.19 | 0.45 | 0.23 | 0.36 |
1n = 17. 2n = 18. 3n = 15 for meat intake in the second trimester. P values were calculated by Spearman’s rank correlation. *P<0.05.
Gestational weight gain (kg) and body composition changes (kg) between the first and third trimesters
| Control group 2 | Intervention group 3 | P 4 | |
|---|---|---|---|
| Gestational weight gain (kg) | 11.6 (9.5, 11.6) | 11.6 (8.9, 13.9) | 0.96 |
| Fat mass gain (kg) | 5.5 (4.0, 6.6) | 6.8 (3.8, 8.4) | 0.34 |
| Fat-free mass gain (kg) | 6.7 (4.9, 8.1) | 5.5 (4.5, 6.7) | 0.22 |
1Values are medians with interquartile range (25th percentile, 75th percentile), kg. 2n = 17. 3n = 18. 4P values were calculated by Mann–Whitney U test.
Levels of serum EPA (eicosapentaenoic acid) (mg/mL) and DHA (docosahexaenoic acid) (mg/mL) in users and nonusers of supplements with fatty acids
| Supplement users | Number of observations | Nonuser of supplements | Number of observations | |
|---|---|---|---|---|
| S-EPA | ||||
| First trimester | 0.054 (0.054, 0.054) | 1 | 0.027 (0.017, 0.037) | 34 |
| Second trimester | 0.071 (0.051, 0.091) | 2 | 0.032 (0.020, 0.039) | 33 |
| Third trimester | 0.032 (0.031, 0.059) | 4 | 0.029 (0.016, 0.051) | 31 |
| S-DHA | ||||
| First trimester | 0.157 (0.157, 0.157) | 1 | 0.138 (0.113, 0.164) | 34 |
| Second trimester | 0.216 (0.196, 0.235) | 2 | 0.177 (0.151, 0.222) | 33 |
| Third trimester | 0.209 (0.187, 0.219) | 4 | 0.196 (0.150, 0.237) | 31 |
Serum levels in women with measurements in all three trimesters.1Values are medians with interquartile range (25th percentile, 75th percentile), mg/mL.